2020/2021: THE CLUSTER IS COMMITTED TO SUPPORTING ITS MEMBERS Faced with the current health crisis, cluster members rallied strongly and... View Article
Author Archives for Adeline Chauvigné
Atlanpole Biotherapies – spearheading the development of tomorrow’s healthcare industry
10 May 20252020/2021: THE CLUSTER IS COMMITTED TO SUPPORTING ITS MEMBERS Faced with the current health crisis, cluster members rallied strongly and... View Article
Focus on the Atlanpole Biotherapies 2021 General Assembly
The 2021 General Assembly was attended by close to 150 people, providing an opportunity to review and assess the cluster’s... View Article
Focus on the Atlanpole Biotherapies 2021 General Assembly
10 May 2025The 2021 General Assembly was attended by close to 150 people, providing an opportunity to review and assess the cluster’s... View Article
Agrocampus Ouest and DelleD create the “AgroHealth Innovation” Chair
DelleD and the Agrocampus Ouest Foundation have joined forces to create “AgroHealth” corporate chair. The aim is to elaborate an... View Article
Agrocampus Ouest and DelleD create the “AgroHealth Innovation” Chair
10 May 2025DelleD and the Agrocampus Ouest Foundation have joined forces to create “AgroHealth” corporate chair. The aim is to elaborate an... View Article
Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate
Valneva, a specialty vaccine company, and Pfizer Inc. (NYSE: PFE), today announced further positive Phase 2 results, including booster response,... View Article
Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate
10 May 2025Valneva, a specialty vaccine company, and Pfizer Inc. (NYSE: PFE), today announced further positive Phase 2 results, including booster response,... View Article
Valneva Continues Expansion of Clinical Trials of its Inactivated COVID-19 Vaccine Candidate VLA2001
Commences recruitment of Adolescents into Phase 3 trial “Cov-Compare” Enrolls participants in the Phase 1/2 Booster Trial Valneva, a specialty vaccine... View Article
Valneva Continues Expansion of Clinical Trials of its Inactivated COVID-19 Vaccine Candidate VLA2001
10 May 2025Commences recruitment of Adolescents into Phase 3 trial “Cov-Compare” Enrolls participants in the Phase 1/2 Booster Trial Valneva, a specialty vaccine... View Article
New partner | Majorelle Avocats
Majorelle Avocats is a law firm specialising in labour law and social security law, based in Nantes and Paris. Its... View Article
New partner | Majorelle Avocats
10 May 2025Majorelle Avocats is a law firm specialising in labour law and social security law, based in Nantes and Paris. Its... View Article
OSE Immunotherapeutics announces H1 2021 results and provides a corporate update
Positive final Phase 3 results for Tedopi® in non-small cell lung cancer (NSCLC) after ICI failure. Positive Phase 1 dose... View Article
OSE Immunotherapeutics announces H1 2021 results and provides a corporate update
10 May 2025Positive final Phase 3 results for Tedopi® in non-small cell lung cancer (NSCLC) after ICI failure. Positive Phase 1 dose... View Article
Naobios manufactures FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials
Naobios today announces the next phase in its partnership with FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious... View Article
Naobios manufactures FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials
10 May 2025Naobios today announces the next phase in its partnership with FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious... View Article
CLEAN CELLS INVESTS OVER €13M IN A NEW BIOPHARMACEUTICAL PRODUCTION SITE
5,300 m2 new facility will quadruple analysis and production capacity, becoming largest site in Europe for biopharmaceuticals quality control services... View Article
CLEAN CELLS INVESTS OVER €13M IN A NEW BIOPHARMACEUTICAL PRODUCTION SITE
10 May 20255,300 m2 new facility will quadruple analysis and production capacity, becoming largest site in Europe for biopharmaceuticals quality control services... View Article
Xenothera signs a memorandum of understanding with the Vietnamese conglomerate Vingroup
Following discussions held under the authority of the Vietnamese Minister of Health, Trân Van Thuân, the Nantes-based company XENOTHERA, which... View Article
Xenothera signs a memorandum of understanding with the Vietnamese conglomerate Vingroup
10 May 2025Following discussions held under the authority of the Vietnamese Minister of Health, Trân Van Thuân, the Nantes-based company XENOTHERA, which... View Article